clock.bio

Senior couple jogging
#Age-related diseases (ARDs) #clock.bio #Healthspan #iPSC #Regenerative Medicine

clock.bio begins mission to extend health span by 20 years

Longevity biotech clock.bio has launched with $4 million in funding to develop regenerative medicines to prevent and treat age-related diseases. The company says its immediate objective is to decode all rejuvenation programmes present in human cells, to build an atlas of disease and rejuvenation targets for… Read More

#Business & Investment #News